K231614 - MiroTract Wound Matrix (FDA 510(k) Clearance)

K231614 is an FDA 510(k) clearance for the MiroTract Wound Matrix. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Reprise Biomedical, Inc. (Plymouth, US). The FDA issued a Cleared decision on December 13, 2023 after a review of 194 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Reprise Biomedical, Inc. devices